Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / NSPR - InspireMD: Revolutionizing The Field Of Vascular Stenting

NSPR - InspireMD: Revolutionizing The Field Of Vascular Stenting

InspireMD Inc.
  • InspireMD develops and commercializes proprietary stent designs with a proprietary mesh.
  • The Company seeks to change the SoC in the treatment of CAD and other invasive indications utilizing an integrated embolic protection stent platform.
  • The Company’s commercialized products are CE mark approved but not approved for sale in the U.S.
  • The Company has initiated a U.S. registrational IDE clinical trial for CGuard EPS in July 2021.

For further details see:

InspireMD: Revolutionizing The Field Of Vascular Stenting
Stock Information
Company Name: InspireMD Inc.
Stock Symbol: NSPR
Market: NASDAQ
Website: inspiremd.com
Menu
NSPR NSPR Quote NSPR Short NSPR News NSPR Articles NSPR Message Board
Get NSPR Alerts

News, Short Squeeze, Breakout and More Instantly...